The PE Ratio as of November 2024 (TTM) for Inventiva S.A. (IVA) is -1.21

According to Inventiva S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -1.21. This represents a change of 18.29% compared to the average of -1.02 of the last 4 quarters.

Inventiva S.A. (IVA) Historical PE Ratio (quarterly & annually)

How has IVA PE Ratio performed in the past?

The mean historical PE Ratio of Inventiva S.A. over the last ten years is -11.08. The current -1.21 PE Ratio has changed 991.77% with respect to the historical average. Over the past ten years (40 quarters), IVA's PE Ratio was at its highest in in the June 2023 quarter at -0.70. The PE Ratio was at its lowest in in the March 2016 quarter at -16.78.

Inventiva S.A. (IVA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Inventiva S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Inventiva S.A. (IVA) Average PE Ratio

How has IVA PE Ratio performed in the past?

The current PE Ratio of Inventiva S.A. (IVA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Inventiva S.A. (IVA) PE Ratio vs. Peers

How is IVA’s PE Ratio compared to its peers?

Inventiva S.A.’s PE Ratio is greater than Mineralys Therapeutics, Inc. (-4.06), greater than Eliem Therapeutics, Inc. (-2.42), greater than Anebulo Pharmaceuticals, Inc. (-4.78), greater than Janux Therapeutics, Inc. (-45.40), greater than Rezolute, Inc. (-4.94), greater than Monte Rosa Therapeutics, Inc. (-5.83), greater than NewAmsterdam Pharma Company N.V. (-10.06), greater than Cullinan Oncology, Inc. (-5.10), greater than Compass Therapeutics, Inc. (-4.48), greater than Arcellx, Inc. (-120.42), less than Ventyx Biosciences, Inc. (-0.86), greater than Immunocore Holdings plc (-30.05), greater than Vaxcyte, Inc. (-21.57), greater than DICE Therapeutics, Inc. (-22.94), less than Verrica Pharmaceuticals Inc. (-0.55), less than LianBio (-0.75), greater than Edgewise Therapeutics, Inc. (-24.30), greater than Vigil Neuroscience, Inc. (-1.57), greater than Innate Pharma S.A. (-3.71), less than HCW Biologics Inc. (-0.78), less than Inhibrx Biosciences, Inc. (0.13),

Build a custom stock screener for Inventiva S.A. (IVA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inventiva S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Inventiva S.A. (IVA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Inventiva S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.